These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1115859)
21. [Disorders of and means of normalizing the deamination of nitrogenous compounds in the liver in experimental neoplasms]. Khuzhamberdiev M; Romanova LA; Neĭfakh EA; Gorkin VZ Vopr Med Khim; 1973; 19(4):415-22. PubMed ID: 4802179 [No Abstract] [Full Text] [Related]
22. The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase. Parkinson D; Callingham BA J Pharm Pharmacol; 1980 Jan; 32(1):49-54. PubMed ID: 6102127 [TBL] [Abstract][Full Text] [Related]
23. [Role of adenine mono- and dinucleotides in ammonia formation in brain tissue]. Buniatian GKh Vopr Biokhim Mozga; 1975; 10():5-32. PubMed ID: 186942 [TBL] [Abstract][Full Text] [Related]
24. [Deamination reactions involving several nitrogen compounds and mammalian radioresistance]. Gorkin VZ; Zeinalov TA; Kudriashov IuB; Riazanov VM Vopr Med Khim; 1977; 23(4):508-15. PubMed ID: 919375 [TBL] [Abstract][Full Text] [Related]
25. A specific and rapid method for determination of adenosine 3'-monophosphate (3'-AMP) content and 3'-AMP forming enzyme activity in rat liver mitochondria, using reversed-phase HPLC with fluorescence detection. Fujimori H; Sato R; Yasuda M; Pan-Hou H Biol Pharm Bull; 1998 Dec; 21(12):1348-51. PubMed ID: 9881652 [TBL] [Abstract][Full Text] [Related]
26. Further characterization of the inhibition of aldehyde dehydrogenase activity by pargyline. Lebsack ME; Anderson AD Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):263-75. PubMed ID: 523771 [TBL] [Abstract][Full Text] [Related]
28. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase. Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880 [No Abstract] [Full Text] [Related]
29. Effects of monamine oxidase inhibitors on qualitive alterations ( Transformation ) of the catalytic properties of amine oxidases. Gorkin VZ; Akopyan ZI; Veryovkina IV; Stesina LN; Samed MM Biochem J; 1971 Feb; 121(3):31P-32P. PubMed ID: 5000918 [No Abstract] [Full Text] [Related]
30. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity]. Severina IS; Klimova GI; Nersisian AA Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine. Grosso DS; Gawienowski AM Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322 [No Abstract] [Full Text] [Related]
32. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl]. Severina IS Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561 [TBL] [Abstract][Full Text] [Related]
33. N-acetyltransferase activity in pineal gland of rats treated with pargyline. Bade P; Rommelspacher H; Strauss S Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):143-7. PubMed ID: 854089 [TBL] [Abstract][Full Text] [Related]
34. Effect of sodium nitrite on monoamine oxidase activity in rat liver and brain. Egashira T; Takano K; Shimizu K; Kurosawa Y; Kamijo K Jpn J Pharmacol; 1971 Apr; 21(2):274-6. PubMed ID: 5314279 [No Abstract] [Full Text] [Related]
35. Enzymes involved in purine metabolism--a review of histochemical localization and functional implications. Moriwaki Y; Yamamoto T; Higashino K Histol Histopathol; 1999 Oct; 14(4):1321-40. PubMed ID: 10506947 [TBL] [Abstract][Full Text] [Related]
36. Pargyline-induced increase in serotonin levels: correlation with inhibition of lordosis in rats. Allen DL; Renner KJ; Luine VN Pharmacol Biochem Behav; 1993 Aug; 45(4):837-41. PubMed ID: 8415823 [TBL] [Abstract][Full Text] [Related]
37. Modulation of mitochondrial adenylate kinase by citric-acid-cycle intermediates. Pradhan TK; Criss WE Eur J Biochem; 1974 Apr; 43(3):541-7. PubMed ID: 4364860 [No Abstract] [Full Text] [Related]
38. [Baygon (2-isopropoxyphenyl-N-methyl carbamate) activation of enzymatic deamination of 2-phenyl-ethylamine]. Zeĭnalov TA Vopr Med Khim; 1985; 31(5):60-4. PubMed ID: 4090367 [TBL] [Abstract][Full Text] [Related]
39. [The role of glutamate dehydrogenase in oxidative deamination of glutamic acid in the brain and liver at different stages of postnatal development]. Aprikian GV; Shaginian VA Vopr Biokhim Mozga; 1973; 8():91-105. PubMed ID: 4804894 [No Abstract] [Full Text] [Related]
40. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors. Moskvitina TA; Medvedev AE Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]